Healthcare / Health Information ServicesMilan
$15.02
+0.16 (+1.08%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 18%
FCF escenarios
weak_data · normalized FCF $-18.7M · quality 43.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
41/100
C
Piotroski
4/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$434M
P/E
26.8x
↑EV/EBITDA
7.6x
↓ROE
5.3%
↑Gross Margin
56.8%
↑Debt/Equity
1.44
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+16.3%
FCF CAGR
—
FCF margin
-1.0%
FCF / Net income
-0.35x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $545.6M · net income $16.2M · FCF $-5.7M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $545.6M | $545.6M | $510.1M | $433.0M | $346.9M |
| Net Income | $16.2M | $16.2M | $103.8M | $5.6M | $9.7M |
| EBITDA | $101.2M | $101.2M | $99.8M | $68.0M | $45.9M |
| EPS | 0.56 | 0.56 | 3.60 | 0.19 | 0.34 |
| Gross Margin | 56.8% | 56.8% | 56.6% | 55.6% | 53.3% |
| Operating Margin | 9.1% | 9.1% | 7.4% | 6.2% | 6.1% |
| Net Margin | 3.0% | 3.0% | 20.4% | 1.3% | 2.8% |
| Balance Sheet | |||||
| Debt/Equity | 1.44 | 1.44 | 1.00 | 1.40 | 1.02 |
| Current Ratio | 1.64 | 1.64 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-5.7M | $-5.7M | $-18.7M | $-31.4M | $-19.7M |
| Returns | |||||
| ROE | 5.3% | 5.3% | 33.7% | 2.4% | 3.9% |
| Valuation | |||||
| P/E | 26.82 | 26.82 | 2.90 | 50.53 | 41.18 |
| EV/EBITDA | 7.57 | 7.57 | 5.65 | 8.23 | 10.45 |
| P/B | 1.42 | 1.42 | 0.98 | 1.20 | 1.62 |
| Growth & Yield | |||||
| Revenue Growth | 7.0% | 7.0% | 17.8% | 24.8% | — |
| EPS Growth | -84.5% | -84.5% | 1795.5% | -44.1% | — |
| Dividend Yield | 4.0% | 4.0% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
33.5%
EPS terminal req.
$1.33
Spread vs growth
-118.0%
5Y implied EPS CAGR
23.6%
EPS terminal req.
$1.61
Spread vs growth
-108.0%
10Y implied EPS CAGR
16.6%
EPS terminal req.
$2.60
Spread vs growth
-101.0%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+46.3%
Start / end P/E
2.9x → 26.8x
EPS bridge
3.60 → 0.56
Residual
-688.1%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.